Added Benefit of Canagliflozin Plus Metformin for Type 2 Diabetes is Not Proven

Share this content:
Added benefit of canagliflozin plus metformin for type 2 diabetes is not proven
Added benefit of canagliflozin plus metformin for type 2 diabetes is not proven
Drug manufacturer's dossier provided no suitable data for any subindication The fixed combination of canagliflozin with metformin (trade name: Vokanamet) has been approved since April 2014 for adults with type 2 diabetes mellitus in whom diet and exercise do not provide adequate glycaemic ...
READ FULL ARTICLE From Medical News Today
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »